UKE Homepage
DE
Section III
B. Leadership and Organizational Structure
B.1 Cancer Center Director and Deputy Director(s)
UCC Hamburg
/2024-relaunch/bilder/startbild-prof.-bokemeyer-quadratisch_st_plus_300x1.jpg)
Prof. Dr. med. Carsten Bokemeyer
Director and Spokesperson – University Cancer Center Hamburg
Director - Department of Oncology, Hematology, Bone Marrow
Transplantation with Section Pneumology, University Medical Center Hamburg Eppendorf
Main Research Focus: Urogenital tumors (treatmentoptions, supportive care/late toxicity/survivorship), earlydrug development in oncology and new multidisciplinarytreatment approaches. Molecular markers andmechanisms of drug resistance in solid tumor models.
2000
Associate Professorship of Medicine at Tübingen University
Since 2004
Appointed as full Professor of Medicine and Director of the Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, Hamburg University
2007 – 2010
Nominated Director of the UCC Hamburg
2010 – 2016
Head Board of Directors UCC Hamburg
Since 2017
Director University Cancer Center Hamburg
Since 2019
Speaker of the CCC-Network of the DKH-funded Oncology Centers of Excellence
2000 – National Award of the German Cancer Society (German Cancer Award: Deutscher Krebspreis)
2000 – Award for Experimental Urological Research2001 Award of the Baden-Württemberg Cancer Society
2002 – Scientific Award of the German Society for Medical Oncology (AIO)
2006 – Anita and Cuno Wieland Award of the University of Heidelberg for translational and clinical cancer research
2014 – Award of the European Society of Medical Oncology (ESMO Award)
2018 – Award of the Wilhelm-Warner-Foundation, Hamburg
/2024-relaunch/bilder/kontaktbild-kai-rothkamm_st_plus_300x1.jpg)
Prof. Dr. rer. nat. Kai Rothkamm
Deputy Director – University Cancer Center Hamburg
Full Professor (W3) of Experimental Radiation Oncology, University Medical Center Hamburg Eppendorf
Main Research Focus: Radiation-inducedDNA double-strand breaks and their repair. Theestablishment and utilization of biomarkers of radiationexposure and effect and the development of strategies formolecular-targeted tumor radiosensitization
2006 – 2008
Cancer Research UK Junior Group Leader, University of Oxford, UK
2008 – 2015
Senior Scientific Group Leader, UKHSA (formerly HPA/PHE), Chilton, Oxfordshire, UK
Since 2015
Professor (W3) in Experimental RadiationOncology, Department of Radiotherapy, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany
Since 2017
Co-Director, University Cancer CenterHamburg
Since 2018 – Deputy Chairman of the Board, Mildred-Scheel Cancer Career Center Hamburg
/2024-relaunch/bilder/kontaktbild-katja-weisel-wei%C3%9F_st_plus_300x1.jpg)
Prof. Dr. med. Katja Christina Weisel
Deputy Director – University Cancer Center Hamburg Deputy Director
Dept. of Oncology, Hematology, BMT with Section of Pneumology – University Medical Center Hamburg Eppendorf
Main Research Focus: Clinical research, Investigator-initiated trialswith focus on difficult-to-treat populations in Multiple Myeloma, cellular therapy
1991 – 1997
PhD. MD studies, University of Ulm,Germany
1997 – 2001
Resident, Internal Medicine and Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany
2001 – 2002
Postdoctoral Fellowship, Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
2003 – 2019
Fellow and Attending Physician, Hematology and Oncology, University Hospital Tuebingen, Head of the Multiple Myeloma Program
2019
Dept. of Oncology, Hematology, BMT with Section of Pneumology– University MedicalCenter Hamburg Eppendorf
2020
Co-Director – University Cancer Center Hamburg
1991 – 1997 Grant student: Studienstiftung des Deutschen Volkes
2001 – 2002 Research Fellowship Grant, German Cancer Foundation
2020 – Research Award of the German Fritz-Acker-Stiftung
2020 – Research Award of the HKG
UCCSH
/2024-relaunch/bilder/claudia-baldus_st_plus_300x1.jpg)
Prof. Dr. med. Claudia Baldus
Board of Directors – University Cancer Center Schleswig Holstein (UCCSH)
Director – Department of Hematology and Oncology, University Hospital Schleswig Holstein (UKSH), Kiel
Vice Dean of the Medical Faculty of the Christian-Albrechts-Universität zu Kiel (CAU)
Chair of the German Association of Hematology and Oncology (DGHO)
Main Research Focus: Molecular characterization of acute leukemia and target identification for novel therapies
2009 – 2018
Senior Physician, Department of Hematology and Oncology, Charité, Berlin
2011 – 2016
Professor (W3) of Hematology, Mildred Scheel Professorship, Charité, Berlin
Since 2018
Full Professor and Director, Department of Hematology and Oncology, UKSH Campus Kiel
Since 2020
Vice Dean, Medical Faculty, Christian-Albrechts-University Kiel
Since 2021
Board of Directors, University Cancer Center Schleswig Holstein (UCCSH)
Since 2022
Speaker, Clinical Research Unit CATCH ALL (DFG CRU 5010)
2001 – 2003 | Postdoctoral Fellow der Dr. Mildred Scheel Foundation, Human Cancer Genetics Program, Ohio State University, Columbus, Ohio, USA
2005 – 2011 | Working group leader, Max-Eder-Junior Research Group Program (German Cancer Aid), Charité, Berlin
2011 – 2016 | Mildred Scheel Professorship, Charité, Berlin
Member of scientific boards: DFG - Fachkollegium, German Cancer Aid - Fachausschuss Forschung, DJCLS
Selected Honors: 2007 - Young Scientist Prize of the DGHO, 2010 - Gutermuth Prize, 2025 - Science Prize, City of Kiel
/2024-relaunch/bilder/nikolas-von-bubnoff_st_plus_300x1.jpg)
Prof. Dr. med. Nikolas von Bubnoff
Board of Directors, University Cancer Center Schleswig Holstein (UCCSH)
Director, Department of Hematology and Oncology, University Hospital Schleswig Holstein (UKSH)
Full Professor of Medicine, Universität zu Lübeck (UzL)
Main Research Focus: Mechanisms of treatment resistance, liquid biopsy, molecular oncology, myeloid neoplasias
2006 – 2012
Senior Physician, Klinikum rechts der Isar, TU-München
2012 – 2018
Deputy Medical Director, Comprehensive Cancer Center Freiburg
2017 – 2018
Executive Senior Consultant, Comprehensive Cancer Center Freiburg
Since 2019
Head, Dpt. of Hematology and Oncology, UKSH Campus Lübeck
Since 2019
Board of Directors, University Cancer Center Schleswig Holstein (UCCSH)
2013 – Science Award (Wissenschaftspreis) of the GIST Group Switzerland
2014 – Richtzenhain Award for Translational Cancer Research
2021 – German Cancer Award (Deutscher Krebspreis) of the German Cancer Society
/2024-relaunch/bilder/anne-letsch_st_plus_300x1.jpg)
Prof. Dr. med. Anne Letsch
Board of Directors – University Cancer Center Schleswig Holstein (UCCSH)
Head Cancer Center UKSH Campus Kiel
Head Medical Oncology – Department of Hematology and Oncology, University Hospital Schleswig Holstein (UKSH), Kiel
Board of Directors and German Representative of the European Association of Palliative Care (EAPC)
Main Research Focus: Patient centered care, supportive and palliative cancer care, tumorimmunology
2009 – 2019
Senior Physician, Department of Hematology and Oncology, Charité, Berlin
2013 – 2019
Head Palliative Care, Department of Hematology and Oncology, Charité, Berlin
Since 2019
Full Professor for Medical Oncology, Department of Hematology and Oncology, UKSH Campus Kiel
Since 2020
Head Cancer Center UKSH Campus Kiel
Since 2021
Board of Directors, University Cancer Center Schleswig Holstein (UCCSH)
Since 2023
Board of Directors EAPC
Member of scientific boards: ESMO-Supportive and Palliative Care Faculty Coordinator (2025-2026), ECO Co-Chair of Survivorship and Quality of life Network (since 2025), German Cancer Society - Member Certification Commissions, AWMF – Member German S3 - Guideline Committees, Co-Lead Working Group Diversity Medicine and Tumorfatigue (DGHO) and Integrated Oncology (German Society for Palliative Medicine - DGP)
Selected Honors: 2005 – Presidential award recipient of the iSBTc (International Society for Biological Therapy of Cancer, today SITC), 2010 – Curt-Meyer Memorial Award, Berlin Cancer Society
/2024-relaunch/bilder/bruno-koehler_st_plus_300x1.jpg)
Prof. Dr. med. Bruno Köhler
Board of Directors, University Cancer Center Schleswig-Holstein (UCCSH)
Senior Managing Physician, Department for Hematology and Oncology, University Hospital Schleswig Holstein (UKSH) Lübeck
Full Professor (W3), Precision Oncology and Early Clinical Trials
Main Research Focus: Translational Oncology and Clinical Trials, Survival and Cell Death Signaling in Gastrointestinal Carcinoma, Cancer in Young Adults (Early Onset Cancer), Patient Participation in Clinical Research and Clinical Trials
2012 – 2014
PostDoc-Fellowship (Group of Prof. Schulze-Bergkamen), Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany
2014 – 2016
Resident Physician and PostDoc, Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany
2022 – 2023
Coordinator Colorectal Cancer Center Heidelberg
2023 – 2025
Senior Physician, NCT Heidelberg
Since 2025
Full Professor (W3), Precision Oncology and Early Clinical Trials at University of Lübeck
Since 2025
Senior Managing Physician, Department of Hematology and Oncology, University Hospital Schleswig Holstein (UKSH) Lübeck
Since 2025
Board of Directors, University Cancer Center Schleswig Holstein (UCCSH)
2019 – Award of the German Liver Foundation
2012 – Thesis Award of Mainz Medical School from the Diethelm-Foundation